The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Circulating tumor HPV-DNA dynamics and neoadjuvant chemotherapy with or without nivolumab in viral-mediated oropharyngeal cancer.
 
Maha Elsebaie
No Relationships to Disclose
 
Evgeny Izumchenko
Stock and Other Ownership Interests - OrisDX
 
Aditya Juloori
Consulting or Advisory Role - AquaLung Therapeutics; AstraZeneca; DaiichiSanko; EMDSerrono; General Electric; GlaxoSmithKline; Isoray; Regeneron
Research Funding - AstraZeneca
Travel, Accommodations, Expenses - EMD Serono
 
Rohan Katipally
No Relationships to Disclose
 
Noura Choudhury
Consulting or Advisory Role - Abbvie; Abbvie; G1 Therapeutics; Harpoon therapeutics; Lilly; Merck; Sanofi
Research Funding - Abbvie (Inst); abbvie (Inst); Amgen (Inst); Harpoon therapeutics (Inst); Merck (Inst); Monte Rosa Therapeutics (Inst); Roche/Genentech (Inst); Seagen (Inst)
Patents, Royalties, Other Intellectual Property - Royalties from Wolters Kluwer (Pocket Oncology).
 
Augustin Vannier
No Relationships to Disclose
 
Elizabeth Blair
Employment - University of Chicago Medicine
 
Frederick Jones
Employment - Sysmex; Sysmex
 
Anna Starus
Employment - Sysmex Inostics Inc.
 
Mark Lingen
No Relationships to Disclose
 
Nicole Cipriani
No Relationships to Disclose
 
Rifat Hasina
No Relationships to Disclose
 
John Cursio
No Relationships to Disclose
 
Daniel Haraf
No Relationships to Disclose
 
Alexander Pearson
Honoraria - Caris Life Sciences
Consulting or Advisory Role - Abbvie; Ayala Pharmaceuticals; Elevar Therapeutics; Prelude Therapeutics; Thermo Fisher Scientific
Research Funding - Abbvie (Inst); EMD Serono (Inst); Kura Oncology (Inst); Merck (Inst)
Travel, Accommodations, Expenses - Caris Life Sciences
 
Everett Vokes
Stock and Other Ownership Interests - Coordination Pharmaceuticals; McKesson
Honoraria - Ascendis Pharma (I); Guidepoint Inc (I); Vision2Voice (I)
Consulting or Advisory Role - Abbvie; AstraZeneca; BioNTech SE; Boehringer Ingelheim; Eikon; Genmab; Merus; MJH Life Sciences; Translational Drug Development LLC
Research Funding - Abbvie; Alliance Pharma; Amgen; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Merck; Novartis
 
Nishant Agrawal
Leadership - OrisDX
Stock and Other Ownership Interests - Haystack Oncology; OrisDX; Privo Technologies
Patents, Royalties, Other Intellectual Property - Patent pending for salivary diagnostics to diagnose oral cancer.
 
Ari Rosenberg
Stock and Other Ownership Interests - Privo Technologies
Consulting or Advisory Role - Astellas Pharma; Eisai; EMD Serono; Geovax Labs; Janssen; Nanobiotix; Novartis; RAPT Therapeutics; Regeneron; Vaccitech
Speakers' Bureau - Coherus Biosciences
Research Funding - Abbvie (Inst); Astellas Pharma (Inst); BeiGene (Inst); Bristol-Myers Squibb/Celgene (Inst); EMD Serono (Inst); Hookipa Biotech (Inst); Janux Therapeutics (Inst); Pfizer (Inst); Purple Biotech (Inst)